As the probiotic market becomes more competitive, clinical trials are a necessary and routine part of product development and marketing. Successful and responsible introduction of probiotic products into the global market requires labeling that provides realistic expectations of health benefits to the consumer and complies with regulatory requirements. In following up with the probiotic workshop in DC last week, this white paper supports what was presented regarding evidence based science within the probiotic segment; covering topics on gut microbiome & supporting structure function claims
